| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3113285 | Medicina Intensiva | 2009 | 8 Pages |
Abstract
When implementing these guidelines, two questions could be asked: 1) Could the abuse of the subclavian vein and avoiding the use of the femoral vein imply a decrease in the incidence of CVCBSI, but an increase in the rate of mechanical complications as pneumothorax and/or hemothorax? 2) Couldn't antimicrobial-impregnated CVCs be used to prevent CVCBSI when the femoral venous access is used?
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
L. Lorente, C. León,